Jose Octavio Filho - Jul 12, 2021 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Medical Officer
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-Fact
Stock symbol
MNPR
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
4
Date filed
7/13/2021, 04:35 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +91.5K $0.00 91.5K Jul 12, 2021 Common Stock 91.5K $5.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 6/48ths on January 12, 2022 and 1/48th per month thereafter.